Royal Bank of Canada’s ContraFect Corporation CFRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-271
| Closed | – | – | 7921 |
|
|
2023
Q3 | $0 | Buy |
271
+87
| +47% | +$82 | ﹤0.01% | 7987 |
|
|
2023
Q2 | $0 | Buy |
+184
| New | +$291 | ﹤0.01% | 8014 |
|
|
2022
Q4 | – | Sell |
-4
| Closed | – | – | 8219 |
|
|
2022
Q3 | $0 | Buy |
+4
| New | +$202 | ﹤0.01% | 8278 |
|
|
2021
Q3 | – | Sell |
-16
| Closed | -$6K | – | 8195 |
|
|
2021
Q2 | $6K | Sell |
16
-10
| -38% | -$3.27K | ﹤0.01% | 7055 |
|
|
2021
Q1 | $10K | Buy |
26
+4
| +18% | +$1.73K | ﹤0.01% | 6835 |
|
|
2020
Q4 | $9K | Buy |
+22
| New | +$9.52K | ﹤0.01% | 6459 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7399 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7128 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7057 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7133 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7158 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6935 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6945 |
|
Other funds holding CFRX
Royal Bank of Canada's CFRX Position: Q4 2023 in Review
Royal Bank of Canada sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 271 shares.
Royal Bank of Canada first reported a position in CFRX in Q4 2020 and held it in 6 quarters. The position peaked at $10K in Q1 2021. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.
- Royal Bank of Canada reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
- Royal Bank of Canada sold 271 ContraFect Corporation shares in Q4 2023.
- Royal Bank of Canada first reported a position in ContraFect Corporation in Q4 2020 and held it in 6 quarters.
- Royal Bank of Canada's ContraFect Corporation position peaked at $10K in Q1 2021.
- 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.